Noramco, officially known as Noramco, Inc., is a leading player in the pharmaceutical industry, headquartered in the United States. Founded in 2000, the company has established itself as a key provider of active pharmaceutical ingredients (APIs) and advanced drug delivery systems, primarily serving the global market. With operational facilities in the US and significant reach in Europe and Asia, Noramco is renowned for its commitment to quality and innovation. The company’s core offerings include a diverse range of controlled substances and non-controlled APIs, distinguished by their rigorous compliance with regulatory standards. Noramco's strategic focus on research and development has led to notable achievements, positioning it as a trusted partner for pharmaceutical companies worldwide. With a strong market presence, Noramco continues to drive advancements in drug formulation and manufacturing, contributing to the evolving landscape of healthcare solutions.
How does Noramco's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Noramco's score of 23 is lower than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Noramco, headquartered in the US, currently does not have available carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges at this time. This lack of data suggests that Noramco may still be in the early stages of establishing its climate commitments or reporting frameworks. As the company progresses, it may consider aligning with industry standards and frameworks such as the Science Based Targets initiative (SBTi) to set measurable and actionable climate goals.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Noramco has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
